glp 1 alzheimers Popular obesity drug fails in hotly anticipated Alzheimer's trials | Science Can popular diabetes and weight-loss
Description
A major clinical trial with 3,500 participants showed that semaglutide reduces disease progression by 24% and lowers the risk of kidney failure and cardiovascular death by 5%
Wang, Q., Wang, D., Cheng, A., Sun, F
Arch Gen Psychiatry
This was not straightforward and took several years to achieve
